SDRIFE Induced by Tofacitinib-Reference-Cited by-同舟云学术

SDRIFE Induced by Tofacitinib

Published:2024-05 Issue:3 Volume:69 Page:272-274
ISSN:0019-5154
Container-title:Indian Journal of Dermatology
language:en
Short-container-title:

Author:

Gnanasuriyan Ramachandran¹,Murali Savitha²,Rajamohanan Remya Raj³,Kuruvila Sheela⁴

Affiliation:

1. From the Department of Dermatology, Venereology and Leprosy, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India

2. Department of Dermatology, Venereology and Leprosy, Pondicherry Institute of Medical Sciences (PIMS), Puducherry, India

3. Department of Dermatology, Venereology and Leprosy, Indira Gandhi Medical College and Research Institute, Pondicherry, India

4. Department of Dermatology, Venereology and Leprosy, Aarupadai Veedu Medical College, Puducherry, India E-mail: kuruvilasheela@gmail.com

Publisher

Medknow

Reference6 articles.

1. Baboon syndrome resulting from systemic drugs:Is there strife between SDRIFE and allergic contact dermatitis syndrome?;Häusermann;Contact Dermatitis,2004

2. Symmetric drug-related intertriginous and flexural exanthema due to itraconazole:An uncommon side effect of a commonly used drug;Mohapatra;Indian Dermatol Online J,2017

3. A method for estimating the probability of adverse drug reactions;Naranjo;Clin Pharmacol Ther,1981

4. Clinical causality assessment for adverse drug reactions;Parida;Indian J Anaesth,2013

5. Preventability and severity assessment in reporting adverse drug reactions;Hartwig;Am J Hosp Pharm,1992

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tofacitinib;Reactions Weekly;2024-08-03